Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Pfizer
Pfizer
Bayer
Pfizer
Ataturk University
Nova Scotia Health Authority
Altamash Institute of Dental Medicine
Hoffmann-La Roche
Jiangsu HengRui Medicine Co., Ltd.
Hoffmann-La Roche
University of Copenhagen
Hoffmann-La Roche
American University of Beirut Medical Center
Ottawa Hospital Research Institute
Gangnam Severance Hospital
Inovio Pharmaceuticals
Novartis
Jiangsu Simcere Pharmaceutical Co., Ltd.
Mundipharma Korea Ltd
GlaxoSmithKline
Seoul National University Hospital
Hospital Sao Joao
Seoul National University Hospital
University Hospital, Clermont-Ferrand
Sanofi
ActiViews Ltd.
ActiViews Ltd.
GlaxoSmithKline
University of Florida
Shandong Luye Pharmaceutical Co., Ltd.